Sacituzumab tirumotecan: previously treated triple-negative breast cancer: consultation records checklist

1. Bring initial and recurrence pathology with ER/PR/HER2 results to confirm the triple-negative subtype
2. List all systemic treatments, dates and progression evidence to verify prior treatment lines
3. Provide recent imaging and brain metastasis assessment records to establish current disease status
4. Prepare blood counts, liver and kidney function and records of oral problems to plan treatment and supportive care

Questions to clarify
- Do I meet the eligibility criteria?
- What are the separate medical and coordination service costs without Chinese health insurance or free-drug assistance?
- How are initial treatment, ongoing treatment, return travel and follow-up arranged?
- Which risks require immediate contact with the hospital?

An initial service consultation does not replace medical assessment.